Cargando…
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive exa...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522520/ https://www.ncbi.nlm.nih.gov/pubmed/37477731 http://dx.doi.org/10.1007/s00535-023-02020-8 |
_version_ | 1785110372991107072 |
---|---|
author | Ashina, Shigeto Masuda, Atsuhiro Yamakawa, Kohei Hamada, Tsuyoshi Tsujimae, Masahiro Tanaka, Takeshi Toyama, Hirochika Sofue, Keitaro Shiomi, Hideyuki Sakai, Arata Kobayashi, Takashi Abe, Shohei Gonda, Masanori Masuda, Shigeto Inomata, Noriko Uemura, Hisahiro Kohashi, Shinya Nagao, Kae Harada, Yoshiyuki Miki, Mika Juri, Noriko Irie, Yosuke Kanzawa, Maki Itoh, Tomoo Inoue, Jun Imai, Toshio Fukumoto, Takumi Kodama, Yuzo |
author_facet | Ashina, Shigeto Masuda, Atsuhiro Yamakawa, Kohei Hamada, Tsuyoshi Tsujimae, Masahiro Tanaka, Takeshi Toyama, Hirochika Sofue, Keitaro Shiomi, Hideyuki Sakai, Arata Kobayashi, Takashi Abe, Shohei Gonda, Masanori Masuda, Shigeto Inomata, Noriko Uemura, Hisahiro Kohashi, Shinya Nagao, Kae Harada, Yoshiyuki Miki, Mika Juri, Noriko Irie, Yosuke Kanzawa, Maki Itoh, Tomoo Inoue, Jun Imai, Toshio Fukumoto, Takumi Kodama, Yuzo |
author_sort | Ashina, Shigeto |
collection | PubMed |
description | BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive examination using an integrative molecular pathological epidemiology database on 169 cases with resected PDAC . The amount of tumor-stromal collagen was quantified through digital imaging analysis for Elastica van Gieson-stained whole-section tumor slides. We analyzed the association of tumor-stromal collagen with gene alterations (KRAS, TP53, CDKN2A/p16, and SMAD4), immune parameters (CD4(+) tumor-infiltrating lymphocytes [TILs], CD8(+) TILs, FOXP3(+) TILs, and tertiary lymphoid structures), and patient prognosis. RESULTS: Low amounts of tumor-stromal collagen were associated with poor differentiation (multivariable OR = 3.82, 95%CI = 1.41–12.2, P = 0.008) and CDKN2A/p16 alteration (OR [95%CI] = 2.06 [1.08–4.02], P = 0.03). Tumors with low collagen levels had shorter overall survival (HR [95%CI] = 2.38 [1.59–3.56], P < 0.0001). In the S-1 and gemcitabine (GEM) treatment groups, low tumor-stromal collagen was linked to poor prognosis of patients with PDAC (S-1 group: multivariable HR [95%CI] = 2.76 [1.36–5.79], P = 0.005; GEM group: multivariate HR [95%CI] = 2.91 [1.34–6.71], P = 0.007). Additionally, low amounts of tumor-stromal collagen were also linked to low levels of CD4(+) TILs (P = 0.046), CD8(+) TILs (P = 0.09), and tertiary lymphoid structures (P = 0.001). CONCLUSIONS: Tumor-stromal collagen deposition may play a crucial role in modulating tumor-immune microenvironment and determining response to adjuvant chemotherapy and patient survival outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00535-023-02020-8. |
format | Online Article Text |
id | pubmed-10522520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-105225202023-09-28 A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma Ashina, Shigeto Masuda, Atsuhiro Yamakawa, Kohei Hamada, Tsuyoshi Tsujimae, Masahiro Tanaka, Takeshi Toyama, Hirochika Sofue, Keitaro Shiomi, Hideyuki Sakai, Arata Kobayashi, Takashi Abe, Shohei Gonda, Masanori Masuda, Shigeto Inomata, Noriko Uemura, Hisahiro Kohashi, Shinya Nagao, Kae Harada, Yoshiyuki Miki, Mika Juri, Noriko Irie, Yosuke Kanzawa, Maki Itoh, Tomoo Inoue, Jun Imai, Toshio Fukumoto, Takumi Kodama, Yuzo J Gastroenterol Original Article―Liver, Pancreas, and Biliary Tract BACKGROUND: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in human PDAC. METHODS: We performed a comprehensive examination using an integrative molecular pathological epidemiology database on 169 cases with resected PDAC . The amount of tumor-stromal collagen was quantified through digital imaging analysis for Elastica van Gieson-stained whole-section tumor slides. We analyzed the association of tumor-stromal collagen with gene alterations (KRAS, TP53, CDKN2A/p16, and SMAD4), immune parameters (CD4(+) tumor-infiltrating lymphocytes [TILs], CD8(+) TILs, FOXP3(+) TILs, and tertiary lymphoid structures), and patient prognosis. RESULTS: Low amounts of tumor-stromal collagen were associated with poor differentiation (multivariable OR = 3.82, 95%CI = 1.41–12.2, P = 0.008) and CDKN2A/p16 alteration (OR [95%CI] = 2.06 [1.08–4.02], P = 0.03). Tumors with low collagen levels had shorter overall survival (HR [95%CI] = 2.38 [1.59–3.56], P < 0.0001). In the S-1 and gemcitabine (GEM) treatment groups, low tumor-stromal collagen was linked to poor prognosis of patients with PDAC (S-1 group: multivariable HR [95%CI] = 2.76 [1.36–5.79], P = 0.005; GEM group: multivariate HR [95%CI] = 2.91 [1.34–6.71], P = 0.007). Additionally, low amounts of tumor-stromal collagen were also linked to low levels of CD4(+) TILs (P = 0.046), CD8(+) TILs (P = 0.09), and tertiary lymphoid structures (P = 0.001). CONCLUSIONS: Tumor-stromal collagen deposition may play a crucial role in modulating tumor-immune microenvironment and determining response to adjuvant chemotherapy and patient survival outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00535-023-02020-8. Springer Nature Singapore 2023-07-21 2023 /pmc/articles/PMC10522520/ /pubmed/37477731 http://dx.doi.org/10.1007/s00535-023-02020-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article―Liver, Pancreas, and Biliary Tract Ashina, Shigeto Masuda, Atsuhiro Yamakawa, Kohei Hamada, Tsuyoshi Tsujimae, Masahiro Tanaka, Takeshi Toyama, Hirochika Sofue, Keitaro Shiomi, Hideyuki Sakai, Arata Kobayashi, Takashi Abe, Shohei Gonda, Masanori Masuda, Shigeto Inomata, Noriko Uemura, Hisahiro Kohashi, Shinya Nagao, Kae Harada, Yoshiyuki Miki, Mika Juri, Noriko Irie, Yosuke Kanzawa, Maki Itoh, Tomoo Inoue, Jun Imai, Toshio Fukumoto, Takumi Kodama, Yuzo A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title | A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title_full | A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title_fullStr | A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title_full_unstemmed | A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title_short | A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
title_sort | comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma |
topic | Original Article―Liver, Pancreas, and Biliary Tract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522520/ https://www.ncbi.nlm.nih.gov/pubmed/37477731 http://dx.doi.org/10.1007/s00535-023-02020-8 |
work_keys_str_mv | AT ashinashigeto acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT masudaatsuhiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT yamakawakohei acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT hamadatsuyoshi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT tsujimaemasahiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT tanakatakeshi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT toyamahirochika acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT sofuekeitaro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT shiomihideyuki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT sakaiarata acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kobayashitakashi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT abeshohei acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT gondamasanori acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT masudashigeto acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT inomatanoriko acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT uemurahisahiro acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kohashishinya acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT nagaokae acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT haradayoshiyuki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT mikimika acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT jurinoriko acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT irieyosuke acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kanzawamaki acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT itohtomoo acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT inouejun acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT imaitoshio acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT fukumototakumi acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kodamayuzo acomprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT ashinashigeto comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT masudaatsuhiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT yamakawakohei comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT hamadatsuyoshi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT tsujimaemasahiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT tanakatakeshi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT toyamahirochika comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT sofuekeitaro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT shiomihideyuki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT sakaiarata comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kobayashitakashi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT abeshohei comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT gondamasanori comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT masudashigeto comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT inomatanoriko comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT uemurahisahiro comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kohashishinya comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT nagaokae comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT haradayoshiyuki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT mikimika comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT jurinoriko comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT irieyosuke comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kanzawamaki comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT itohtomoo comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT inouejun comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT imaitoshio comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT fukumototakumi comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma AT kodamayuzo comprehensiveanalysisoftumorstromalcollageninrelationtopathologicalmolecularandimmunecharacteristicsandpatientsurvivalinpancreaticductaladenocarcinoma |